Zobrazeno 1 - 10
of 84
pro vyhledávání: '"H. Rochlitz"'
Publikováno v:
Materialwissenschaft und Werkstofftechnik. 42:279-288
Bei der Ableitung von Lastannahmen als einem wesentlichen Element des Produktentwicklungs- und Auslegungsprozesses sind die spezifischen Ansatze und Randbedingungen des Nachweisprozesses zu berucksichtigen. In dem Beitrag werden wichtige Bausteine un
Publikováno v:
Allergy. 63:148-155
Insulin allergy in patients with diabetes mellitus on insulin treatment is a rare condition. It is suspected upon noticing immediate symptoms following insulin injections. The immediate vital implications for the patient call for prompt diagnosis and
Autor:
Jochen Spranger, Traci Kruthaupt, Andreas Pfeiffer, H. Rochlitz, Corinna Koebnick, Matthias H. Tschöp, Martin O. Weickert, Juliane Kampe, Bärbel Otto, Torsten P. Vahl, Paul T. Pfluger, U Cuntz, Stephen C. Benoit, Tamara R. Castañeda, David A. D'Alessio, M. Moehlig
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 92:583-588
Recent findings suggest that low plasma peptide YY (PYY) levels may contribute to diet-induced human obesity and justify PYY replacement therapy. Although the pharmacological value of PYY is controversial, further study of the secretion of the precur
Autor:
V. Kullmann, Martin O. Weickert, Knut Mai, Andreas Pfeiffer, Sven Diederich, Volker Bähr, Martin A. Osterhoff, Jochen Spranger, H. Rochlitz, J. Andres, Matthias Möhlig, Thomas Bobbert
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 91:1501-1507
There is considerable evidence that metabolic factors such as insulin resistance may induce hyperandrogenemia in polycystic ovary syndrome. However, other metabolic factors such as free fatty acids (FFAs) may also contribute to androgen excess.The ob
Autor:
Pawel Namsolleck, H. Rochlitz, Jens J. Holst, Martin O. Weickert, Joachim Spranger, Corinna Koebnick, Michael Ristow, Natalia Rudovich, Martin A. Osterhoff, Matthias Möhlig, Andreas Pfeiffer
Publikováno v:
Diabetologia. 48:2343-2353
Insoluble dietary fibre intake is associated, by unknown mechanisms, with a reduced risk of type 2 diabetes. We investigated whether a short-term dietary intervention with purified insoluble fibres influences acute and delayed responses of glucose, i
Autor:
Jochen Spranger, S. Diederich, Andreas Pfeiffer, MA Arafat, H. Rochlitz, Bärbel Otto, Matthias Möhlig, Matthias H. Tschöp, Volker Bähr
Publikováno v:
European Journal of Endocrinology. 153:397-402
Objective: It is well known that i.m. glucagon administration stimulates GH and cortisol release in humans, although the mechanisms are unclear. These effects are similar to those described for ghrelin on somatotroph and corticotroph function. The ai
Autor:
M. Möhlig, T Bobbert, H. Rochlitz, Knut Mai, Joachim Spranger, Martin A. Osterhoff, S. Akpulat, M. O. Weickert, Andreas Pfeiffer
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 130:1061-1066
Introduction Obesity is a risk factor for type 2 diabetes, hypertension, dyslipidemia and cardiovascular disease. We aimed to analyse the changes of parameters of the metabolic syndrome and to investigate which markers are useful in the prediction of
Autor:
Michael Ristow, M. Tschoep, M. Moehlig, Natalia Rudovich, D. Dick, Andreas Pfeiffer, H. Rochlitz, Bärbel Otto, Jochen Spranger
Publikováno v:
Regulatory Peptides. 127:95-99
Systemic ghrelin concentration falls rapidly after nutrient ingestion in vivo. The effect incretins on ghrelin secretion in humans remains unclear. We quantified circulating ghrelin concentrations under hyperglycemic conditions combined with infusion
Publikováno v:
Diabetes. 53:2359-2365
Our objective was to study whether young first-degree relatives of patients with type 2 diabetes (FDRs) have altered insulin secretion and insulin clearance in response to gastric inhibitory polypeptide (GIP) in combination with glucose and arginine.
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 112:395-400
The effects of a combination of repaglinide and metformin on the insulin secretion pattern and insulin sensitivity were studied in a fixed-dose, open-label, placebo-controlled cross-over study. Eleven patients with T2 DM were allocated in random orde